Bacterial and viral co-infections complicating severe influenza: Incidence and impact among 507 U.S. patients, 2013-14

Nirav S Shah, Jared A Greenberg, Moira C McNulty, Kevin S Gregg, James Riddell 4th, Julie E Mangino, Devin M Weber, Courtney L Hebert, Natalie S Marzec, Michelle A Barron, Fredy Chaparro-Rojas, Alejandro Restrepo, Vagish Hemmige, Kunatum Prasidthrathsint, Sandra Cobb, Loreen Herwaldt, Vanessa Raabe, Christopher R Cannavino, Andrea Green Hines, Sara H Bares, Philip B Antiporta, Tonya Scardina, Ursula Patel, Gail Reid, Parvin Mohazabnia, Suresh Kachhdiya, Binh-Minh Le, Connie J Park, Belinda Ostrowsky, Ari Robicsek, Becky A Smith, Jeanmarie Schied, Micah M Bhatti, Stockton Mayer, Monica Sikka, Ivette Murphy-Aguilu, Priti Patwari, Shira R Abeles, Francesca J Torriani, Zainab Abbas, Sophie Toya, Katherine Doktor, Anindita Chakrabarti, Susanne Doblecki-Lewis, David J Looney, Michael Z David, Nirav S Shah, Jared A Greenberg, Moira C McNulty, Kevin S Gregg, James Riddell 4th, Julie E Mangino, Devin M Weber, Courtney L Hebert, Natalie S Marzec, Michelle A Barron, Fredy Chaparro-Rojas, Alejandro Restrepo, Vagish Hemmige, Kunatum Prasidthrathsint, Sandra Cobb, Loreen Herwaldt, Vanessa Raabe, Christopher R Cannavino, Andrea Green Hines, Sara H Bares, Philip B Antiporta, Tonya Scardina, Ursula Patel, Gail Reid, Parvin Mohazabnia, Suresh Kachhdiya, Binh-Minh Le, Connie J Park, Belinda Ostrowsky, Ari Robicsek, Becky A Smith, Jeanmarie Schied, Micah M Bhatti, Stockton Mayer, Monica Sikka, Ivette Murphy-Aguilu, Priti Patwari, Shira R Abeles, Francesca J Torriani, Zainab Abbas, Sophie Toya, Katherine Doktor, Anindita Chakrabarti, Susanne Doblecki-Lewis, David J Looney, Michael Z David

Abstract

Background: Influenza acts synergistically with bacterial co-pathogens. Few studies have described co-infection in a large cohort with severe influenza infection.

Objectives: To describe the spectrum and clinical impact of co-infections.

Study design: Retrospective cohort study of patients with severe influenza infection from September 2013 through April 2014 in intensive care units at 33 U.S. hospitals comparing characteristics of cases with and without co-infection in bivariable and multivariable analysis.

Results: Of 507 adult and pediatric patients, 114 (22.5%) developed bacterial co-infection and 23 (4.5%) developed viral co-infection. Staphylococcus aureus was the most common cause of co-infection, isolated in 47 (9.3%) patients. Characteristics independently associated with the development of bacterial co-infection of adult patients in a logistic regression model included the absence of cardiovascular disease (OR 0.41 [0.23-0.73], p=0.003), leukocytosis (>11K/μl, OR 3.7 [2.2-6.2], p<0.001; reference: normal WBC 3.5-11K/μl) at ICU admission and a higher ICU admission SOFA score (for each increase by 1 in SOFA score, OR 1.1 [1.0-1.2], p=0.001). Bacterial co-infections (OR 2.2 [1.4-3.6], p=0.001) and viral co-infections (OR 3.1 [1.3-7.4], p=0.010) were both associated with death in bivariable analysis. Patients with a bacterial co-infection had a longer hospital stay, a longer ICU stay and were likely to have had a greater delay in the initiation of antiviral administration than patients without co-infection (p<0.05) in bivariable analysis.

Conclusions: Bacterial co-infections were common, resulted in delay of antiviral therapy and were associated with increased resource allocation and higher mortality.

Keywords: Co-infection; ICU; Influenza A (H1N1) pdm09; MRSA; Severe influenza; Staphylococcus aureus.

Copyright © 2016 Elsevier B.V. All rights reserved.

Figures

Fig. 1
Fig. 1
Antibiogram of Staphylococcus aureus isolates (n = 47) from co-infections, showing the percent that were resistant or intermediate to selected antibacterial drugs from 47 patients with severe influenza in the U.S. between September 1, 2013 and April 1, 2014.
Fig. 2
Fig. 2
Percentage of community-acquired and hospital-acquired co-infections attributed to Staphylococcus aureus, Enterobacteriaceae and Pseudomonas sp. among 507 patients with severe influenza in the U.S. between September 1, 2013 and April 1, 2014.

References

    1. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179–186.
    1. Brundage J.F., Shanks G.D. Deaths from bacterial pneumonia during 1918–19 influenza pandemic. Emerg. Infect. Dis. 2008;14(8):1193–1199.
    1. Morens D.M., Taubenberger J.K., Fauci A.S. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J. Infect. Dis. 2008;198(7):962–970.
    1. Murata Y., Walsh E.E., Falsey A.R. Pulmonary complications of interpandemic influenza A in hospitalized adults. J. Infect. Dis. 2007;195(7):1029–1037.
    1. Morens D.M., Fauci A.S. The 1918 influenza pandemic: insights for the 21st century. J. Infect. Dis. 2007;195(7):1018–1028.
    1. Johnson N.P.A.S., Mueller J. Updating the accounts: global mortality of the 1918–1920 Spanish influenza pandemic. Bull. Hist. Med. 2002;76(1):105–115.
    1. Chien Y.-W., Klugman K.P., Morens D.M. Bacterial pathogens and death during the 1918 influenza pandemic. N. Engl. J. Med. 2009;361(26):2582–2583.
    1. McCullers J.A. The co-pathogenesis of influenza viruses with bacteria in the lung. Nat. Rev. Microbiol. 2014;12(4):252–262.
    1. Seki M., Kosai K., Yanagihara K., Higashiyama Y., Kurihara S., Izumikawa K. Disease severity in patients with simultaneous influenza and bacterial pneumonia. Intern. Med. 2007;46(13):953–958.
    1. Rice T.W., Rubinson L., Uyeki T.M., Vaughn F.L., John B.B., Miller R.R. Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit. Care Med. 2012;40(5):1487–1498.
    1. Schwarzmann S.W., Adler J.L., Sullivan R.J., Marine W.M. Bacterial pneumonia during the Hong Kong influenza epidemic of 1968–1969. Arch. Intern. Med. 1971;127(6):1037–1041.
    1. Martin C.M., Kunin C.M., Gottlieb L.S., Finland M. Asian influenza A in Boston, 1957–1958. II. Severe staphylococcal pneumonia complicating influenza. AMA Arch. Intern. Med. 1959;103(4):532–542.
    1. Robertson L., Caley J.P., Moore J. Importance of Staphylococcus aureus in pneumonia in the 1957 epidemic of influenza A. Lancet. 1958;2(August (7040)):233–236.
    1. Gillet Y., Issartel B., Vanhems P., Fournet J.-C., Lina G., Bes M. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002;359(9308):753–759.
    1. Finelli L., Fiore A., Dhara R., Brammer L., Shay D.K., Kamimoto L. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics. 2008;122(4):805–811.
    1. Watt J.P., Wolfson L.J., O’Brien K.L., Henkle E., Deloria-Knoll M., McCall N. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet. 2009;374(9693):903–911.
    1. Chaussee M.S., Sandbulte H.R., Schuneman M.J., Depaula F.P., Addengast L.A., Schlenker E.H. Inactivated and live, attenuated influenza vaccines protect mice against influenza: Streptococcus pyogenes super-infections. Vaccine. 2011;29(21):3773–3781.
    1. Martín-Loeches I., Sanchez-Corral A., Diaz E., Granada R.M., Zaragoza R., Villavicencio C. Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) virus. Chest. 2011;139(3):555–562.
    1. Estenssoro E., Ríos F.G., Apezteguía C., Reina R., Neira J., Ceraso D.H. Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. Am. J. Respir. Crit. Care Med. 2010;182(1):41–48.
    1. Nin N., Soto L., Hurtado J., Lorente J.A., Buroni M., Arancibia F. Clinical characteristics and outcomes of patients with 2009 influenza A(H1N1) virus infection with respiratory failure requiring mechanical ventilation. J. Crit. Care. 2011;26(2):186–192.
    1. Shah N.S., Greenberg J.A., McNulty M.C., Gregg K.S., Riddell J., Mangino J.E. Severe influenza in 33 US hospitals, 2013–2014: complications and risk factors for death in 507 patients. Infect. Control Hosp. Epidemiol. 2015;(July):1–10.
    1. Harris P.A., Taylor R., Thielke R., Payne J., Gonzalez N., Conde J.G. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inform. 2009;42(2):377–381.
    1. Dawood F.S., Chaves S.S., Pérez A., Reingold A., Meek J., Farley M.M. Complications and associated bacterial coinfections among children hospitalized with seasonal or pandemic influenza, United States, 2003–2010. J. Infect. Dis. 2014;209(5):686–694.
    1. Cillóniz C., Ewig S., Menéndez R., Ferrer M., Polverino E., Reyes S. Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia. J. Infect. 2012;65(3):223–230.
    1. Jones R.N. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin. Infect. Dis. 2010;51(Suppl. 1):S81–87.
    1. Viasus D., Paño-Pardo J.R., Pachón J., Campins A., López-Medrano F., Villoslada A. Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. Clin. Microbiol. Infect. 2011;17(5):738–746.
    1. Drews A.L., Atmar R.L., Glezen W.P., Baxter B.D., Piedra P.A., Greenberg S.B. Dual respiratory virus infections. Clin. Infect. Dis. 1997;25(6):1421–1429.
    1. Renois F., Talmud D., Huguenin A., Moutte L., Strady C., Cousson J. Rapid detection of respiratory tract viral infections and coinfections in patients with influenza-like illnesses by use of reverse transcription-PCR DNA microarray systems. J. Clin. Microbiol. 2010;48(11):3836–3842.
    1. Martin E.T., Kuypers J., Wald A., Englund J.A. Multiple versus single virus respiratory infections: viral load and clinical disease severity in hospitalized children. Influenza Other Respir. Viruses. 2012;6(1):71–77.

Source: PubMed

Подписаться